Gracure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.82 Cr
as on 16-11-2024
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.48 Cr
as on 16-11-2024
- Satisfied Charges ₹ 18.45 Cr
as on 16-11-2024
- Revenue 1.70%
(FY 2023)
- Profit -2.42%
(FY 2023)
- Ebitda -2.01%
(FY 2023)
- Net Worth 21.79%
(FY 2023)
- Total Assets 14.34%
(FY 2023)
About Gracure Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.25 Cr and a paid-up capital of Rs 2.82 Cr.
The company currently has active open charges totaling ₹9.48 Cr. The company has closed loans amounting to ₹18.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amreshwar Bhargava, Parag Bhargava, Pradeep Rastogi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232DL1992PLC049002
- Company No.
049002
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Jun 1992
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gracure Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amreshwar Bhargava  | Managing Director | 25-Nov-1992 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parag Bhargava | Whole-Time Director | 10-Aug-2002 | Current |
| Pradeep Rastogi | Whole-Time Director | 13-Mar-2002 | Current |
| Sudhir Bhargava | Whole-Time Director | 27-Nov-2001 | Current |
| Harshad Vaid | Director | 05-May-1995 | Current |
Financial Performance of Gracure Pharmaceuticals.
Gracure Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.7% increase. The company also saw a slight decrease in profitability, with a 2.42% decrease in profit. The company's net worth Soared by an impressive increase of 21.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gracure Pharmaceuticals?
In 2022, Gracure Pharmaceuticals had a promoter holding of 77.81% and a public holding of 22.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 07 Oct 2022 | ₹9.50 M | Open |
Hdfc Bank Limited Creation Date: 13 Sep 2021 | ₹1.12 M | Open |
Hdfc Bank Limited Creation Date: 10 Jun 2021 | ₹5.00 M | Open |
How Many Employees Work at Gracure Pharmaceuticals?
Gracure Pharmaceuticals has a workforce of 461 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gracure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gracure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
